Main navigation english

Canadian Public Health Association

Program

Preliminary PROGRAM 

Download the Preliminary Program (PDF, 648 KB)

Updated Thursday 2 March; 11:00 EST

Program is subject to change.

All times are Eastern Time.

Tuesday 25 aPRIL

7:15 - 8:30

Co-developed learning activities

9:00 - 10:30 Opening Plenary: Applying pandemic learnings to routine immunization programs
10:30 - 11:15 Refreshment break with Sponsors and Exhibitors
11:15 - 12:45

Concurrent Sessions

  • Economic evidence for national and provincial/ territorial vaccine decision-making in Canada
  • Ensuring immunization of structurally-disadvantaged populations – Black People and other people of colour
  • Mind The Gap! Filling the space between misinformation and the different types of vaccine hesitancy
  • New vaccine landscapes: Regulation of new platforms, immunization routes, and vaccine strategies for respiratory viruses
  • Oral presentations

12:45 - 13:45

Networking Lunch

13:50 - 14:50 Poster Presentations
15:00 - 16:30

Concurrent Sessions

  • Enhancing knowledge in immunity and immunization through modelling
  • Exploring peoples-specific and community-specific facilitators and barriers to HPV immunization uptake in First Nations, Inuit, Métis, and urban Indigenous communities
  • Improving vaccination discussions and uptake in pregnancy: The value of applying implementation science to improve clinical practices
  • Mpox vaccine response in Canada: Emergency response necessitating interplay between multiple levels of public health
  • Oral presentations
17:00 - 18:30

Co-developed learning activity

Wednesday 26 aPRIL

7:15 - 8:30

Co-developed learning activities

9:00 - 10:30 Plenary II: Unlearning and undoing systemic white supremacy and Indigenous-specific racism in Public Health
10:30 - 11:15 Refreshment break with Sponsors and Exhibitors
11:15 - 12:45

Concurrent Sessions

  • COVID-19 vaccine decision-making, accessibility and information challenges for structurally-disadvantaged populations
  • Expanding the types of vaccine providers as a means of expanding capacity during the COVID-19 pandemic: An innovative solution or a risky provisional measure?
  • RSV vaccine development
  • Sero-epidemiology of vaccine preventable diseases in Canada: Blood operators in action
  • Oral presentations

12:45 - 13:45

Networking Lunch

13:50 - 14:50 Poster Presentations
15:00 - 16:30

Concurrent Sessions

  • Behavioural insights into vaccination: Theories and methods for understanding and increasing uptake
  • Mining for silver linings: Exploring learnings and innovations from our mass-immunization efforts during the COVID-19 pandemic response
  • Monitoring the safety of vaccination during pregnancy in Canada: Where do we need to go from here? 
  • Opportunities and challenges for National Immunization Technical Advisory Groups through the COVID-19 pandemic
  • Oral presentations
17:00 - 18:30

Co-developed learning activity

thursday 27 aPRIL

7:15 - 8:30

Co-developed learning activities

9:00 - 10:00 Plenary III: A new era of adult immunization
10:00 - 10:30 Refreshment break
10:30 - 12:00

Concurrent Sessions

  • 2021 Immunization communication tool for health care providers
  • Addressing the needs of immunocomprised populations
  • The Immunization Partnership Fund: A spotlight on community-led vaccine confidence initiatives for structurally-disadvantaged populations
  • What's new with NACI
  • Oral presentations

12:00 - 12:30

Lunch

12:30 - 14:00 Plenary IV & Closing: Preventing and preparing for the re-emergence of vaccine-preventable diseases